Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Benazepril (Lotensin)
1.2.3 Captopril
1.2.4 Enalapril (Vasotec)
1.2.5 Fosinopril
1.2.6 Lisinopril (Prinivil, Zestril)
1.2.7 Moexipril
1.2.8 Perindopril
1.2.9 Quinapril (Accupril)
1.2.10 Ramipril (Altace)
1.2.11 Trandolapril
1.3 Market by Application
1.3.1 Global Angiotensin Converting Enzyme Inhibitors Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Coronary Artery Disease
1.3.3 Heart Failure
1.3.4 Diabetes
1.3.5 Chronic Kidney Diseases
1.3.6 Heart Attacks
1.3.7 Scleroderma
1.3.8 Migraines
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Angiotensin Converting Enzyme Inhibitors Market Perspective (2018-2033)
2.2 Angiotensin Converting Enzyme Inhibitors Growth Trends by Region
2.2.1 Global Angiotensin Converting Enzyme Inhibitors Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Angiotensin Converting Enzyme Inhibitors Historic Market Size by Region (2018-2023)
2.2.3 Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Region (2024-2033)
2.3 Angiotensin Converting Enzyme Inhibitors Market Dynamics
2.3.1 Angiotensin Converting Enzyme Inhibitors Industry Trends
2.3.2 Angiotensin Converting Enzyme Inhibitors Market Drivers
2.3.3 Angiotensin Converting Enzyme Inhibitors Market Challenges
2.3.4 Angiotensin Converting Enzyme Inhibitors Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Angiotensin Converting Enzyme Inhibitors Players by Revenue
3.1.1 Global Top Angiotensin Converting Enzyme Inhibitors Players by Revenue (2018-2023)
3.1.2 Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Players (2018-2023)
3.2 Global Angiotensin Converting Enzyme Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Angiotensin Converting Enzyme Inhibitors Revenue
3.4 Global Angiotensin Converting Enzyme Inhibitors Market Concentration Ratio
3.4.1 Global Angiotensin Converting Enzyme Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Angiotensin Converting Enzyme Inhibitors Revenue in 2022
3.5 Angiotensin Converting Enzyme Inhibitors Key Players Head office and Area Served
3.6 Key Players Angiotensin Converting Enzyme Inhibitors Product Solution and Service
3.7 Date of Enter into Angiotensin Converting Enzyme Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Angiotensin Converting Enzyme Inhibitors Breakdown Data by Type
4.1 Global Angiotensin Converting Enzyme Inhibitors Historic Market Size by Type (2018-2023)
4.2 Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Type (2024-2033)
5 Angiotensin Converting Enzyme Inhibitors Breakdown Data by Application
5.1 Global Angiotensin Converting Enzyme Inhibitors Historic Market Size by Application (2018-2023)
5.2 Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Angiotensin Converting Enzyme Inhibitors Market Size (2018-2033)
6.2 North America Angiotensin Converting Enzyme Inhibitors Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023)
6.4 North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Angiotensin Converting Enzyme Inhibitors Market Size (2018-2033)
7.2 Europe Angiotensin Converting Enzyme Inhibitors Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023)
7.4 Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size (2018-2033)
8.2 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Region (2018-2023)
8.4 Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Angiotensin Converting Enzyme Inhibitors Market Size (2018-2033)
9.2 Latin America Angiotensin Converting Enzyme Inhibitors Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023)
9.4 Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size (2018-2033)
10.2 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023)
10.4 Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Angiotensin Converting Enzyme Inhibitors Introduction
11.1.4 Pfizer Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Angiotensin Converting Enzyme Inhibitors Introduction
11.2.4 AstraZeneca Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Angiotensin Converting Enzyme Inhibitors Introduction
11.3.4 Novartis AG Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.3.5 Novartis AG Recent Development
11.4 Daiichi Sankyo, Inc
11.4.1 Daiichi Sankyo, Inc Company Detail
11.4.2 Daiichi Sankyo, Inc Business Overview
11.4.3 Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Introduction
11.4.4 Daiichi Sankyo, Inc Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.4.5 Daiichi Sankyo, Inc Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Angiotensin Converting Enzyme Inhibitors Introduction
11.5.4 Sanofi Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Angiotensin Converting Enzyme Inhibitors Introduction
11.6.4 Merck Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.6.5 Merck Recent Development
11.7 Abbott
11.7.1 Abbott Company Detail
11.7.2 Abbott Business Overview
11.7.3 Abbott Angiotensin Converting Enzyme Inhibitors Introduction
11.7.4 Abbott Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
11.7.5 Abbott Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Benazepril (Lotensin)
Table 3. Key Players of Captopril
Table 4. Key Players of Enalapril (Vasotec)
Table 5. Key Players of Fosinopril
Table 6. Key Players of Lisinopril (Prinivil, Zestril)
Table 7. Key Players of Moexipril
Table 8. Key Players of Perindopril
Table 9. Key Players of Quinapril (Accupril)
Table 10. Key Players of Ramipril (Altace)
Table 11. Key Players of Trandolapril
Table 12. Global Angiotensin Converting Enzyme Inhibitors Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 13. Global Angiotensin Converting Enzyme Inhibitors Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 14. Global Angiotensin Converting Enzyme Inhibitors Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Angiotensin Converting Enzyme Inhibitors Market Share by Region (2018-2023)
Table 16. Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 17. Global Angiotensin Converting Enzyme Inhibitors Market Share by Region (2024-2033)
Table 18. Angiotensin Converting Enzyme Inhibitors Market Trends
Table 19. Angiotensin Converting Enzyme Inhibitors Market Drivers
Table 20. Angiotensin Converting Enzyme Inhibitors Market Challenges
Table 21. Angiotensin Converting Enzyme Inhibitors Market Restraints
Table 22. Global Angiotensin Converting Enzyme Inhibitors Revenue by Players (2018-2023) & (US$ Million)
Table 23. Global Angiotensin Converting Enzyme Inhibitors Market Share by Players (2018-2023)
Table 24. Global Top Angiotensin Converting Enzyme Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme Inhibitors as of 2022)
Table 25. Ranking of Global Top Angiotensin Converting Enzyme Inhibitors Companies by Revenue (US$ Million) in 2022
Table 26. Global 5 Largest Players Market Share by Angiotensin Converting Enzyme Inhibitors Revenue (CR5 and HHI) & (2018-2023)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Angiotensin Converting Enzyme Inhibitors Product Solution and Service
Table 29. Date of Enter into Angiotensin Converting Enzyme Inhibitors Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Angiotensin Converting Enzyme Inhibitors Market Size by Type (2018-2023) & (US$ Million)
Table 32. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Type (2018-2023)
Table 33. Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 34. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Type (2024-2033)
Table 35. Global Angiotensin Converting Enzyme Inhibitors Market Size by Application (2018-2023) & (US$ Million)
Table 36. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Application (2018-2023)
Table 37. Global Angiotensin Converting Enzyme Inhibitors Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 38. Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share by Application (2024-2033)
Table 39. North America Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 40. North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023) & (US$ Million)
Table 41. North America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033) & (US$ Million)
Table 42. Europe Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033) & (US$ Million)
Table 45. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 46. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Region (2018-2023) & (US$ Million)
Table 47. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size by Region (2024-2033) & (US$ Million)
Table 48. Latin America Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 49. Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023) & (US$ Million)
Table 50. Latin America Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033) & (US$ Million)
Table 51. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 52. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Country (2018-2023) & (US$ Million)
Table 53. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size by Country (2024-2033) & (US$ Million)
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Angiotensin Converting Enzyme Inhibitors Product
Table 57. Pfizer Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. AstraZeneca Company Detail
Table 60. AstraZeneca Business Overview
Table 61. AstraZeneca Angiotensin Converting Enzyme Inhibitors Product
Table 62. AstraZeneca Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 63. AstraZeneca Recent Development
Table 64. Novartis AG Company Detail
Table 65. Novartis AG Business Overview
Table 66. Novartis AG Angiotensin Converting Enzyme Inhibitors Product
Table 67. Novartis AG Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 68. Novartis AG Recent Development
Table 69. Daiichi Sankyo, Inc Company Detail
Table 70. Daiichi Sankyo, Inc Business Overview
Table 71. Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Product
Table 72. Daiichi Sankyo, Inc Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 73. Daiichi Sankyo, Inc Recent Development
Table 74. Sanofi Company Detail
Table 75. Sanofi Business Overview
Table 76. Sanofi Angiotensin Converting Enzyme Inhibitors Product
Table 77. Sanofi Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Merck Company Detail
Table 80. Merck Business Overview
Table 81. Merck Angiotensin Converting Enzyme Inhibitors Product
Table 82. Merck Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Abbott Company Detail
Table 85. Abbott Business Overview
Table 86. Abbott Angiotensin Converting Enzyme Inhibitors Product
Table 87. Abbott Revenue in Angiotensin Converting Enzyme Inhibitors Business (2018-2023) & (US$ Million)
Table 88. Abbott Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Angiotensin Converting Enzyme Inhibitors Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Angiotensin Converting Enzyme Inhibitors Market Share by Type: 2022 VS 2033
Figure 3. Benazepril (Lotensin) Features
Figure 4. Captopril Features
Figure 5. Enalapril (Vasotec) Features
Figure 6. Fosinopril Features
Figure 7. Lisinopril (Prinivil, Zestril) Features
Figure 8. Moexipril Features
Figure 9. Perindopril Features
Figure 10. Quinapril (Accupril) Features
Figure 11. Ramipril (Altace) Features
Figure 12. Trandolapril Features
Figure 13. Global Angiotensin Converting Enzyme Inhibitors Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 14. Global Angiotensin Converting Enzyme Inhibitors Market Share by Application: 2022 VS 2033
Figure 15. Coronary Artery Disease Case Studies
Figure 16. Heart Failure Case Studies
Figure 17. Diabetes Case Studies
Figure 18. Chronic Kidney Diseases Case Studies
Figure 19. Heart Attacks Case Studies
Figure 20. Scleroderma Case Studies
Figure 21. Migraines Case Studies
Figure 22. Others Case Studies
Figure 23. Angiotensin Converting Enzyme Inhibitors Report Years Considered
Figure 24. Global Angiotensin Converting Enzyme Inhibitors Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 25. Global Angiotensin Converting Enzyme Inhibitors Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 26. Global Angiotensin Converting Enzyme Inhibitors Market Share by Region: 2022 VS 2033
Figure 27. Global Angiotensin Converting Enzyme Inhibitors Market Share by Players in 2022
Figure 28. Global Top Angiotensin Converting Enzyme Inhibitors Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Angiotensin Converting Enzyme Inhibitors as of 2022)
Figure 29. The Top 10 and 5 Players Market Share by Angiotensin Converting Enzyme Inhibitors Revenue in 2022
Figure 30. North America Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. North America Angiotensin Converting Enzyme Inhibitors Market Share by Country (2018-2033)
Figure 32. United States Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Canada Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Europe Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Europe Angiotensin Converting Enzyme Inhibitors Market Share by Country (2018-2033)
Figure 36. Germany Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. France Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. U.K. Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Italy Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Russia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Nordic Countries Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Asia-Pacific Angiotensin Converting Enzyme Inhibitors Market Share by Region (2018-2033)
Figure 44. China Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Japan Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. South Korea Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Latin America Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Latin America Angiotensin Converting Enzyme Inhibitors Market Share by Country (2018-2033)
Figure 52. Mexico Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Brazil Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Middle East & Africa Angiotensin Converting Enzyme Inhibitors Market Share by Country (2018-2033)
Figure 56. Turkey Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia Angiotensin Converting Enzyme Inhibitors Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 59. AstraZeneca Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 60. Novartis AG Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 61. Daiichi Sankyo, Inc Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 62. Sanofi Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 63. Merck Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 64. Abbott Revenue Growth Rate in Angiotensin Converting Enzyme Inhibitors Business (2018-2023)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed